{"id":348576,"date":"2026-11-16T14:14:12","date_gmt":"2026-11-16T08:44:12","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=348576"},"modified":"2026-11-16T14:14:12","modified_gmt":"2026-11-16T08:44:12","slug":"ferro-alloys-and-power-company-pharmaceuticals-maker-and-electrical-goods-maker-stocks-roadmap-moorland-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/ferro-alloys-and-power-company-pharmaceuticals-maker-and-electrical-goods-maker-stocks-roadmap-moorland-list\/","title":{"rendered":"3 Ferro Alloys and Power Company, Pharmaceuticals Maker and Electrical Goods Maker Stocks With a Strong Future Roadmap: Sarda Energy, Marksans Pharma and Havells India"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E84;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Sarda Energy, Marksans Pharma and Havells India: ROE of 13.8% to 17.9% and FY22 to FY26 revenue CAGR of 10.6% to 18.6%. Prices as of 13 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E84;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three ferro alloy, pharma and electrical stocks to watch are Sarda Energy, Marksans Pharma and Havells India. Their return on equity ranges from 13.8% to 17.9%, and their revenue compound annual growth from FY22 to FY26 ranges from 10.6% to 18.6%. Havells India has the highest return on equity at 17.9%, while Marksans Pharma has the fastest revenue growth at 18.6% a year. Prices are based on the 13 November 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>Ferro alloy, pharma and electrical stocks let investors follow companies that serve a growing part of the Indian economy. Sarda Energy, Marksans Pharma and Havells India cover a ferro alloys and power company, a pharmaceuticals maker and an electrical goods maker.<\/p>\n<p>This list covers three ferro alloy, pharma and electrical stocks with complete current figures: Sarda Energy, Marksans Pharma and Havells India. Every figure comes from the latest reported financials and the 13 November 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=ferro-alloys-and-power-company-pharmaceuticals-maker-and-electrical-goods-maker-stocks-roadmap-moorland-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/ferro-alloys-and-power-company-pharmaceuticals-maker-and-electrical-goods-maker-stocks-roadmap-moorland-list\/#What_Are_Ferro_Alloy_Pharma_and_Electrical_Stocks\" title=\"What Are Ferro Alloy, Pharma and Electrical Stocks?\">What Are Ferro Alloy, Pharma and Electrical Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/ferro-alloys-and-power-company-pharmaceuticals-maker-and-electrical-goods-maker-stocks-roadmap-moorland-list\/#Ferro_Alloy_Pharma_and_Electrical_Stocks_at_a_Glance\" title=\"Ferro Alloy, Pharma and Electrical Stocks at a Glance\">Ferro Alloy, Pharma and Electrical Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/ferro-alloys-and-power-company-pharmaceuticals-maker-and-electrical-goods-maker-stocks-roadmap-moorland-list\/#Why_Do_Ferro_Alloy_Pharma_and_Electrical_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Ferro Alloy, Pharma and Electrical Stocks Have a Strong Roadmap in India?\">Why Do Ferro Alloy, Pharma and Electrical Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/ferro-alloys-and-power-company-pharmaceuticals-maker-and-electrical-goods-maker-stocks-roadmap-moorland-list\/#Why_Sarda_Energy_Features_Among_These_Ferro_Alloy_Pharma_and_Electrical_Stocks\" title=\"Why Sarda Energy Features Among These Ferro Alloy, Pharma and Electrical Stocks\">Why Sarda Energy Features Among These Ferro Alloy, Pharma and Electrical Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/ferro-alloys-and-power-company-pharmaceuticals-maker-and-electrical-goods-maker-stocks-roadmap-moorland-list\/#Why_Marksans_Pharma_Features_Among_These_Ferro_Alloy_Pharma_and_Electrical_Stocks\" title=\"Why Marksans Pharma Features Among These Ferro Alloy, Pharma and Electrical Stocks\">Why Marksans Pharma Features Among These Ferro Alloy, Pharma and Electrical Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/ferro-alloys-and-power-company-pharmaceuticals-maker-and-electrical-goods-maker-stocks-roadmap-moorland-list\/#Why_Havells_India_Features_Among_These_Ferro_Alloy_Pharma_and_Electrical_Stocks\" title=\"Why Havells India Features Among These Ferro Alloy, Pharma and Electrical Stocks\">Why Havells India Features Among These Ferro Alloy, Pharma and Electrical Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/ferro-alloys-and-power-company-pharmaceuticals-maker-and-electrical-goods-maker-stocks-roadmap-moorland-list\/#Sarda_Energy_vs_Marksans_Pharma_vs_Havells_India_on_Key_Financials\" title=\"Sarda Energy vs Marksans Pharma vs Havells India on Key Financials\">Sarda Energy vs Marksans Pharma vs Havells India on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/ferro-alloys-and-power-company-pharmaceuticals-maker-and-electrical-goods-maker-stocks-roadmap-moorland-list\/#Key_Risks_to_Check_Before_Investing_in_Ferro_Alloy_Pharma_and_Electrical_Stocks\" title=\"Key Risks to Check Before Investing in Ferro Alloy, Pharma and Electrical Stocks\">Key Risks to Check Before Investing in Ferro Alloy, Pharma and Electrical Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/ferro-alloys-and-power-company-pharmaceuticals-maker-and-electrical-goods-maker-stocks-roadmap-moorland-list\/#Final_Thoughts_on_Ferro_Alloy_Pharma_and_Electrical_Stocks\" title=\"Final Thoughts on Ferro Alloy, Pharma and Electrical Stocks\">Final Thoughts on Ferro Alloy, Pharma and Electrical Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/ferro-alloys-and-power-company-pharmaceuticals-maker-and-electrical-goods-maker-stocks-roadmap-moorland-list\/#What_are_ferro_alloy_pharma_and_electrical_stocks\" title=\"What are ferro alloy, pharma and electrical stocks?\">What are ferro alloy, pharma and electrical stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/ferro-alloys-and-power-company-pharmaceuticals-maker-and-electrical-goods-maker-stocks-roadmap-moorland-list\/#Which_ferro_alloy_pharma_and_electrical_stocks_are_covered_in_this_list\" title=\"Which ferro alloy, pharma and electrical stocks are covered in this list?\">Which ferro alloy, pharma and electrical stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/ferro-alloys-and-power-company-pharmaceuticals-maker-and-electrical-goods-maker-stocks-roadmap-moorland-list\/#Why_do_ferro_alloy_pharma_and_electrical_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do ferro alloy, pharma and electrical stocks have a strong future roadmap in India?\">Why do ferro alloy, pharma and electrical stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/ferro-alloys-and-power-company-pharmaceuticals-maker-and-electrical-goods-maker-stocks-roadmap-moorland-list\/#How_has_Sarda_Energy_performed_financially\" title=\"How has Sarda Energy performed financially?\">How has Sarda Energy performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/ferro-alloys-and-power-company-pharmaceuticals-maker-and-electrical-goods-maker-stocks-roadmap-moorland-list\/#How_has_Marksans_Pharma_performed_financially\" title=\"How has Marksans Pharma performed financially?\">How has Marksans Pharma performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/ferro-alloys-and-power-company-pharmaceuticals-maker-and-electrical-goods-maker-stocks-roadmap-moorland-list\/#How_has_Havells_India_performed_financially\" title=\"How has Havells India performed financially?\">How has Havells India performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/ferro-alloys-and-power-company-pharmaceuticals-maker-and-electrical-goods-maker-stocks-roadmap-moorland-list\/#What_risks_should_investors_check_before_buying_ferro_alloy_pharma_and_electrical_stocks\" title=\"What risks should investors check before buying ferro alloy, pharma and electrical stocks?\">What risks should investors check before buying ferro alloy, pharma and electrical stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/ferro-alloys-and-power-company-pharmaceuticals-maker-and-electrical-goods-maker-stocks-roadmap-moorland-list\/#Is_this_list_of_ferro_alloy_pharma_and_electrical_stocks_investment_advice\" title=\"Is this list of ferro alloy, pharma and electrical stocks investment advice?\">Is this list of ferro alloy, pharma and electrical stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Ferro_Alloy_Pharma_and_Electrical_Stocks\"><\/span><strong>What Are Ferro Alloy, Pharma and Electrical Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Ferro alloy, pharma and electrical stocks are listed companies that make ferro alloys, steel and power for industry, make and sell medicines for India and global markets, and make fans, switches, cables and home appliances. Their earnings depend on steel demand, medicine demand and home electricals demand.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Ferro_Alloy_Pharma_and_Electrical_Stocks_at_a_Glance\"><\/span><strong>Ferro Alloy, Pharma and Electrical Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/sardaen\/sarda-energy-and-minerals-ltd-share-price-today\">Sarda Energy<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">444.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">16,079<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">22.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.36<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/marksans\/marksans-pharma-ltd-share-price-today\">Marksans Pharma<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">318.5<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12,994<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">24.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">35.7<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13.8<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/havells\/havells-india-ltd-share-price-today\">Havells India<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,161<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">68,928<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">42.2<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">44.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.03<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, all three trade at a P\/E below their industry P\/E, which means the market is pricing them at a lower multiple than their peer group. Readers comparing ferro alloy, pharma and electrical stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Ferro_Alloy_Pharma_and_Electrical_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Ferro Alloy, Pharma and Electrical Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Ferro alloy, pharma and electrical stocks have a strong roadmap in India because strong steel output, wider access to quality medicines and rising household appliance use keep widening the market for these companies.<\/p>\n<ul>\n<li><strong>Ferro alloys.<\/strong> Steel makers need alloy inputs.<\/li>\n<li><strong>Pharmaceuticals.<\/strong> Patients need quality medicines.<\/li>\n<li><strong>Electrical goods.<\/strong> Homes buy more appliances.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_Sarda_Energy_Features_Among_These_Ferro_Alloy_Pharma_and_Electrical_Stocks\"><\/span><strong>Why Sarda Energy Features Among These Ferro Alloy, Pharma and Electrical Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the ferro alloy, pharma and electrical stocks on this list, Sarda Energy and Minerals is a Raipur-based integrated company producing ferro alloys, sponge iron, steel billets and power, supported by its own mines.<\/p>\n<p>In the June 2026 quarter, revenue grew 0.2% year on year to Rs 1,717 crore, while net profit rose 9.4% to Rs 463 crore. Revenue rose from Rs 3,964 crore in FY22 to Rs 5,928 crore in FY26, a compound annual growth rate of 10.6%.<\/p>\n<p>Net profit grew from Rs 808 crore in FY22 to Rs 1,063 crore in FY26, which works out to a compound annual growth rate of 7.1%. The company has a return on equity of 15.0%, a debt to equity ratio of 0.36 and a market capitalisation of Rs 16,079 crore. The stock trades at a P\/E of 14.0, below the industry P\/E of 22.4.<\/p>\n<p><strong>Roadmap:<\/strong> The company is growing capacity in steel and power while using captive mines to support its cost base. An integrated model lets it capture margin at several steps of production.<\/p>\n<p><strong>What to watch:<\/strong> Track capacity additions, captive mine output and power plant performance.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Marksans_Pharma_Features_Among_These_Ferro_Alloy_Pharma_and_Electrical_Stocks\"><\/span><strong>Why Marksans Pharma Features Among These Ferro Alloy, Pharma and Electrical Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the steel input maker, medicine maker and switch shares on this list, Marksans Pharma is a Mumbai-based drug maker that produces over-the-counter and prescription formulations at plants in India and sells them in the United Kingdom, the United States, Australia and other markets.<\/p>\n<p>The company has a return on equity of 13.8%, a debt to equity ratio of 0.11 and a market capitalisation of Rs 12,994 crore. The stock trades at a P\/E of 24.9, below the industry P\/E of 35.7.<\/p>\n<p>Revenue rose from Rs 1,533 crore in FY22 to Rs 3,033 crore in FY26, a compound annual growth rate of 18.6%. Net profit grew from Rs 187 crore in FY22 to Rs 420 crore in FY26, which works out to a compound annual growth rate of 22.5%. In the June 2026 quarter, revenue grew 38.5% year on year to Rs 866 crore.<\/p>\n<p><strong>Roadmap:<\/strong> The company is adding capacity and new products for regulated markets, which supports export growth. A focus on over-the-counter products gives it steady, repeat demand.<\/p>\n<p><strong>What to watch:<\/strong> Track export growth, new product approvals and plant utilisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Havells_India_Features_Among_These_Ferro_Alloy_Pharma_and_Electrical_Stocks\"><\/span><strong>Why Havells India Features Among These Ferro Alloy, Pharma and Electrical Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, Havells India is a leading electrical products company that sells fans, lighting, switchgear, wires and cables, and consumer appliances, along with Lloyd air conditioners.<\/p>\n<p>Revenue rose from Rs 14,099 crore in FY22 to Rs 23,022 crore in FY26, a compound annual growth rate of 13.0%. Net profit grew from Rs 1,196 crore in FY22 to Rs 1,689 crore in FY26, which works out to a compound annual growth rate of 9.0%.<\/p>\n<p>In the June 2026 quarter, revenue grew 19.0% year on year to Rs 6,572 crore. The company has a return on equity of 17.9%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 68,928 crore. The stock trades at a P\/E of 42.2, below the industry P\/E of 44.3.<\/p>\n<p><strong>Roadmap:<\/strong> The company sells through a wide dealer network and keeps adding premium products and new categories such as air conditioners and water heaters. Capacity expansion in cables and appliances supports future growth.<\/p>\n<p><strong>What to watch:<\/strong> Check growth in the cables and Lloyd air conditioner businesses.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sarda_Energy_vs_Marksans_Pharma_vs_Havells_India_on_Key_Financials\"><\/span><strong>Sarda Energy vs Marksans Pharma vs Havells India on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three ferro alloy, pharma and electrical stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Sarda Energy<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,964<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,928<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10.6%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,063<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.9%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Marksans Pharma<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,533<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,033<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.6%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">420<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13.8%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Havells India<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14,099<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">23,022<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13.0%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,689<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7.3%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Havells India posts the highest return on equity in this group at 17.9%. Havells India has the largest FY26 revenue at Rs 23,022 crore, and Marksans Pharma shows the fastest revenue growth with a 18.6% compound annual rate. A useful habit with ferro alloy, pharma and electrical stocks is to check each new quarterly result against the capacity plans the company described earlier.<\/p>\n<p>The June 2026 quarter, the latest reported, gives a fresh read on momentum:<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Q1 FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Q1 FY27 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Year-on-Year Growth<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Sarda Energy<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,713<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,717<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.2%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Marksans Pharma<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">626<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">866<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">38.5%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Havells India<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,525<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">6,572<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">19.0%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_Ferro_Alloy_Pharma_and_Electrical_Stocks\"><\/span><strong>Key Risks to Check Before Investing in Ferro Alloy, Pharma and Electrical Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these ferro alloy, pharma and electrical stocks, the main points are: Long-term steel input maker, medicine maker and switch shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.<\/p>\n<ul>\n<li><strong>Commodity prices.<\/strong> Selling prices follow global and domestic markets.<\/li>\n<li><strong>Regulatory approvals.<\/strong> Plant inspections and approvals can affect supplies.<\/li>\n<li><strong>Raw material costs.<\/strong> Ingredient and packaging prices can move margins.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter ferro alloy, pharma and electrical stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_Ferro_Alloy_Pharma_and_Electrical_Stocks\"><\/span><strong>Final Thoughts on Ferro Alloy, Pharma and Electrical Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Ferro alloy, pharma and electrical stocks reward investors who follow demand trends, order books and margins together. Sarda Energy, Marksans Pharma and Havells India each have a clear plan to grow. Based on the 13 November 2026 close, Sarda Energy trades at Rs 444.3, Marksans Pharma at Rs 318.5 and Havells India at Rs 1,161. Valuation matters as much as growth, so compare each company&#8217;s P\/E with its industry P\/E before adding any of these ferro alloy, pharma and electrical stocks to a watchlist.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track ferro alloy, pharma and electrical stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_ferro_alloy_pharma_and_electrical_stocks\"><\/span><strong>What are ferro alloy, pharma and electrical stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Ferro alloy, pharma and electrical stocks are listed companies that make ferro alloys, steel and power for industry, make and sell medicines for India and global markets, and make fans, switches, cables and home appliances. Their earnings depend on steel demand, medicine demand and home electricals demand. This list looks at three of them, Sarda Energy, Marksans Pharma and Havells India, using reported FY22 to FY26 financials and the 13 November 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_ferro_alloy_pharma_and_electrical_stocks_are_covered_in_this_list\"><\/span><strong>Which ferro alloy, pharma and electrical stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers Sarda Energy, Marksans Pharma and Havells India. Based on the 13 November 2026 close, Sarda Energy traded at Rs 444.3, Marksans Pharma at Rs 318.5 and Havells India at Rs 1,161. Their return on equity ranges from 13.8% to 17.9%, and their revenue compound annual growth from FY22 to FY26 ranges from 10.6% to 18.6%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_ferro_alloy_pharma_and_electrical_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do ferro alloy, pharma and electrical stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Ferro alloy, pharma and electrical stocks have a strong roadmap in India because strong steel output, wider access to quality medicines and rising household appliance use keep widening the market for these companies. The main drivers are as follows. Ferro alloys. Steel makers need alloy inputs. Pharmaceuticals. Patients need quality medicines. Electrical goods. Homes buy more appliances. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Sarda_Energy_performed_financially\"><\/span><strong>How has Sarda Energy performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 3,964 crore in FY22 to Rs 5,928 crore in FY26, a compound annual growth rate of 10.6%. Net profit grew from Rs 808 crore in FY22 to Rs 1,063 crore in FY26, which works out to a compound annual growth rate of 7.1%. In the June 2026 quarter, revenue grew 0.2% year on year to Rs 1,717 crore, while net profit rose 9.4% to Rs 463 crore. The company has a return on equity of 15.0%, a debt to equity ratio of 0.36 and a market capitalisation of Rs 16,079 crore. The stock trades at a P\/E of 14.0, below the industry P\/E of 22.4. Looking ahead, the company is growing capacity in steel and power while using captive mines to support its cost base. An integrated model lets it capture margin at several steps of production.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Marksans_Pharma_performed_financially\"><\/span><strong>How has Marksans Pharma performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 1,533 crore in FY22 to Rs 3,033 crore in FY26, a compound annual growth rate of 18.6%. Net profit grew from Rs 187 crore in FY22 to Rs 420 crore in FY26, which works out to a compound annual growth rate of 22.5%. In the June 2026 quarter, revenue grew 38.5% year on year to Rs 866 crore. The company has a return on equity of 13.8%, a debt to equity ratio of 0.11 and a market capitalisation of Rs 12,994 crore. The stock trades at a P\/E of 24.9, below the industry P\/E of 35.7. Looking ahead, the company is adding capacity and new products for regulated markets, which supports export growth. A focus on over-the-counter products gives it steady, repeat demand.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Havells_India_performed_financially\"><\/span><strong>How has Havells India performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 14,099 crore in FY22 to Rs 23,022 crore in FY26, a compound annual growth rate of 13.0%. Net profit grew from Rs 1,196 crore in FY22 to Rs 1,689 crore in FY26, which works out to a compound annual growth rate of 9.0%. In the June 2026 quarter, revenue grew 19.0% year on year to Rs 6,572 crore. The company has a return on equity of 17.9%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 68,928 crore. The stock trades at a P\/E of 42.2, below the industry P\/E of 44.3. Looking ahead, the company sells through a wide dealer network and keeps adding premium products and new categories such as air conditioners and water heaters. Capacity expansion in cables and appliances supports future growth.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_ferro_alloy_pharma_and_electrical_stocks\"><\/span><strong>What risks should investors check before buying ferro alloy, pharma and electrical stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying ferro alloy, pharma and electrical stocks. Commodity prices. Selling prices follow global and domestic markets. Regulatory approvals. Plant inspections and approvals can affect supplies. Raw material costs. Ingredient and packaging prices can move margins. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_ferro_alloy_pharma_and_electrical_stocks_investment_advice\"><\/span><strong>Is this list of ferro alloy, pharma and electrical stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 13 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are ferro alloy, pharma and electrical stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Ferro alloy, pharma and electrical stocks are listed companies that make ferro alloys, steel and power for industry, make and sell medicines for India and global markets, and make fans, switches, cables and home appliances. Their earnings depend on steel demand, medicine demand and home electricals demand. This list looks at three of them, Sarda Energy, Marksans Pharma and Havells India, using reported FY22 to FY26 financials and the 13 November 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which ferro alloy, pharma and electrical stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers Sarda Energy, Marksans Pharma and Havells India. Based on the 13 November 2026 close, Sarda Energy traded at Rs 444.3, Marksans Pharma at Rs 318.5 and Havells India at Rs 1,161. Their return on equity ranges from 13.8% to 17.9%, and their revenue compound annual growth from FY22 to FY26 ranges from 10.6% to 18.6%.\"}},{\"@type\":\"Question\",\"name\":\"Why do ferro alloy, pharma and electrical stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Ferro alloy, pharma and electrical stocks have a strong roadmap in India because strong steel output, wider access to quality medicines and rising household appliance use keep widening the market for these companies. The main drivers are as follows. Ferro alloys. Steel makers need alloy inputs. Pharmaceuticals. Patients need quality medicines. Electrical goods. Homes buy more appliances. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has Sarda Energy performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 3,964 crore in FY22 to Rs 5,928 crore in FY26, a compound annual growth rate of 10.6%. Net profit grew from Rs 808 crore in FY22 to Rs 1,063 crore in FY26, which works out to a compound annual growth rate of 7.1%. In the June 2026 quarter, revenue grew 0.2% year on year to Rs 1,717 crore, while net profit rose 9.4% to Rs 463 crore. The company has a return on equity of 15.0%, a debt to equity ratio of 0.36 and a market capitalisation of Rs 16,079 crore. The stock trades at a P\/E of 14.0, below the industry P\/E of 22.4. Looking ahead, the company is growing capacity in steel and power while using captive mines to support its cost base. An integrated model lets it capture margin at several steps of production.\"}},{\"@type\":\"Question\",\"name\":\"How has Marksans Pharma performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 1,533 crore in FY22 to Rs 3,033 crore in FY26, a compound annual growth rate of 18.6%. Net profit grew from Rs 187 crore in FY22 to Rs 420 crore in FY26, which works out to a compound annual growth rate of 22.5%. In the June 2026 quarter, revenue grew 38.5% year on year to Rs 866 crore. The company has a return on equity of 13.8%, a debt to equity ratio of 0.11 and a market capitalisation of Rs 12,994 crore. The stock trades at a P\/E of 24.9, below the industry P\/E of 35.7. Looking ahead, the company is adding capacity and new products for regulated markets, which supports export growth. A focus on over-the-counter products gives it steady, repeat demand.\"}},{\"@type\":\"Question\",\"name\":\"How has Havells India performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 14,099 crore in FY22 to Rs 23,022 crore in FY26, a compound annual growth rate of 13.0%. Net profit grew from Rs 1,196 crore in FY22 to Rs 1,689 crore in FY26, which works out to a compound annual growth rate of 9.0%. In the June 2026 quarter, revenue grew 19.0% year on year to Rs 6,572 crore. The company has a return on equity of 17.9%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 68,928 crore. The stock trades at a P\/E of 42.2, below the industry P\/E of 44.3. Looking ahead, the company sells through a wide dealer network and keeps adding premium products and new categories such as air conditioners and water heaters. Capacity expansion in cables and appliances supports future growth.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying ferro alloy, pharma and electrical stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying ferro alloy, pharma and electrical stocks. Commodity prices. Selling prices follow global and domestic markets. Regulatory approvals. Plant inspections and approvals can affect supplies. Raw material costs. Ingredient and packaging prices can move margins. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of ferro alloy, pharma and electrical stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 13 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Ferro Alloy, Pharma and Electrical Stocks with a strong future roadmap: Sarda Energy, Marksans Pharma and Havells India. Compare price, valuation, return on equity and revenue growth as of 13 November 2026.<\/p>\n","protected":false},"author":38,"featured_media":348575,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[24185,3803,10987,24186,7147,9051,24184,24182,15302,24183],"class_list":["post-348576","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-alloys-and-power","tag-best-stocks","tag-ferro-alloy","tag-formulations-and-home-electricals-stocks","tag-havells-india","tag-marksans-pharma","tag-medicine-maker-and-switch-shares","tag-pharma-and-electrical-stocks","tag-sarda-energy","tag-steel-input-maker"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["348575"],"rank_math_title":["Ferro Alloy, Pharma and Electrical Stocks"],"rank_math_description":["Compare 3 ferro alloy, pharma and electrical stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 13 Nov 2026."],"rank_math_focus_keyword":["ferro alloy, pharma and electrical stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/3-ferro-alloys-and-power-company-pharmaceuticals-maker-and-electrical-goods.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/348576","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=348576"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/348576\/revisions"}],"predecessor-version":[{"id":348578,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/348576\/revisions\/348578"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/348575"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=348576"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=348576"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=348576"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}